“Extending protection to vendors, clients, and suppliers is critical to maintaining trust and operational integrity.”
biotech solutions
In the healthcare industry, JPMorgan provides specialized solutions to biotechnology, pharmaceutical and other life sciences companies.
The banker supports start-up companies in the preclinical stages of development and commercialization.
Share your expertise on the financial and regulatory challenges that companies face within your industry.
JPMorgan connects clients with experts around the world to help life sciences companies manage their international operations.
We help companies with unique needs related to industry subsectors such as medical devices, diagnostics, and biopharmaceuticals.
Through our digital platform, JPMorgan enables companies to evolve and grow in healthcare by enabling them to increase efficiency, reduce costs, save time and make more informed decisions in their operations.
JP Morgan Healthcare Advisory Board
In December 2025, U.S. healthcare leaders convened on JPMorgan's Healthcare Advisory Board.
The event demonstrated how AI can be practically implemented in healthcare settings and discussed the impact of AI on the industry.
For example, Hartford Healthcare, which operates multiple hospitals and specialty facilities across the United States, partnered with MIT to develop an AI platform.
This collaboration has created practical solutions such as an emergency department scheduling system and a platform for analyzing patient data.
The platform has been demonstrated to reduce patient length of stay by one full day at six hospitals in Connecticut.
Hartford Healthcare used AI tools for clinical documentation across physician practices.
Implementing this technology in clinical practice has reduced staff documentation burden while maintaining detailed records, allowing physicians to spend more time caring for patients.
